Femy stock news.

Nov 15, 2023 · Femasys Inc (FEMY) stock is trading at $1.10 as of 10:08 AM on Wednesday, Nov 15, an increase of $0.17, or 18.28% from the previous closing price of $0.93. The stock has traded between $1.05 and $1.25 so far today. Volume today is 2,748,419 compared to average volume of 3,456,068. Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods that may have been lost or stolen.LifeSci Advisors, LLC. 917-741-7792. [email protected]. Femasys Inc. Investor Contact: [email protected]. Media Contact: [email protected]. - The 510 (k) Clearance from the United States Food ...by Vandana Singh, Benzinga Editor. July 27, 2023 12:26 PM | 1 min read. Femasys Inc. FEMY. shares are trading higher after the company announced that the United States Patent and Trademark Office ...The company has $10.71 million in cash and $209,098 in debt, giving a net cash position of $10.50 million or $0.66 per share. Cash & Cash Equivalents. 10.71M.

Sep 29, 2023 · By Eddie Pan, InvestorPlace Financial News Writer Sep 29, 2023, 12:18 pm EST. The cost to borrow T2 Biosystems ( TTOO) tallies in at 37.62%, compared to 16.06% on Sept. 18. Meanwhile, 10% owner CR ... View Our Latest Stock Report on FEMY. Femasys Trading Up 4.9 %. Shares of FEMY stock opened at $0.96 on Monday. Femasys has a 12-month low of $0.25 and a 12-month high of $4.75. The company has a market capitalization of $14.54 million, a P/E ratio of -0.99 and a beta of -3.56.Femasys Inc (NASDAQ:FEMY) trade information. Femasys Inc (FEMY) registered a -2.33% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.33% in intraday trading to $0.93 this Friday, 12/01/23, hitting a weekly high. The stock’s 5-day price performance is -9.71%, and it has moved …

The Fly 12 days ago. Track Femasys Inc (FEMY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get …

Snap Inc. 12.52. +0.21. +1.71%. Get Sea Ltd (SE:NYSE) real-time stock quotes, news, price and financial information from CNBC.Femasys Inc. (Nasdaq: FEMY) gained 510 (k) product clearance for FemaSeed, commenced patient enrollment in the FINALE trial for FemBloc, and raised $11.3 million. The company also achieved compliance with Nasdaq's minimum bid price requirement and announced financial results for Q3 2023.Webull offers Femasys Inc stock information, including NASDAQ: FEMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FEMY stock news, and many more online research tools to help you make informed decisions. That’s a massive surge in trading volume compared to Femasys’ daily average of about 3.3 million shares. FEMY stock is up 180.9% as of Tuesday morning after closing out Monday down 63.2% year ...Femasys Stock Price, News & Analysis (NASDAQ:FEMY) $0.98 -0.03 (-2.98%) (As of 11/29/2023 ET) Compare Today's Range …

On September 29, 2023, FEMY stock experienced significant volatility and a sharp increase in price. Starting the day at an opening price of $1.88, the stock reached a high of $3.62 before closing at $3.62. This represents a substantial gain from the previous day’s close of $1.51. The trading volume for FEMY stock on this day was 3,599,194 ...

Enter your email address below to receive the latest news and earnings results for FEMY and its competitors with MarketBeat's FREE daily newsletter. FEMY Earnings Date and Information Femasys has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 based off prior year ...

CHRS : 1.5900 (-0.62%) FEMY : 1.2200 (+0.83%) Femasys To Host Key Opinion Leader Event on FemBloc, a First-of-its-Kind Medical Solution for Permanent Birth Control and an Important Option for Women Post Overturn of Roe v. Wade Globe Newswire - Wed Jul 20, 2022. Webinar to be held Thursday, July 28th @ 10:30am EDT... What this means: Femasys Inc (FEMY) gets an Overall Rank of 65, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.Femasys Inc. (NASDAQ: FEMY) appoints Dr. James Liu, M.D., a renowned figure from a top-ranked academic gynecology program, as Chief Medical Officer. Dr. Liu's appointment comes as Femasys accelerates the commercialization of its product pipeline, including a new therapeutic for artificial insemination, FemaSeed®. With significant …Nov 28, 2023 · Femasys was founded in 2004 and went public in June 2021 at $13 per share, rising approximately $32M after fees and expenses. The Company then followed the general market downward for the next two... Discover historical prices for FEMY stock on Yahoo Finance. View daily, weekly or monthly format back to when Femasys Inc. stock was issued.Get the latest Femasys Inc. (FEMY) stock news and headlines to help you in your trading and investing decisions.

Femasys (FEMY) stock price is up 1,250% but there are 2 key risks. The remarkable Femasys (NASDAQ: FEMY) stock price comeback continued on Monday as demand for the shares continued. The shares surged by more than 45% on Friday and gained by another 15% in the pre-mar... 7 weeks ago - Invezz.High Growth Earnings: FEMY is forecast to remain unprofitable over the next 3 years. Revenue vs Market: FEMY's revenue (64.4% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: FEMY's revenue (64.4% per year) is forecast to grow faster than 20% per year.27 Sep 2023 ... Femasys (NASDAQ: FEMY) stock price has made a strong comeback in the past few days as investors cheer the company's FDA news. The shares surged ...Jul 6, 2021 · 10/03/23 8:49 AM. Post #257. – Femasys demonstrates compliance with harmonized regulatory requirements for Australia, Brazil, Japan, Canada and the USA –. – Femasys (FEMY) is committed to bringing innovative solutions to women around the world –. Kathy Lee-Sepsick. https://www.femasys.com. Femasys Inc., a biomedical company, develops novel solutions for women's healthcare market in the United States and internationally. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a ...10/04/2023 - 08:30 AM . ATLANTA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative diagnostic products, today announced that it will be exhibiting at the annual meeting ...

Recent News. The remarkable Femasys (NASDAQ: FEMY) stock price comeback continued on Monday as demand for the shares continued. The shares surged by more than 45% on Friday and gained by another 15% in the pre-market session. It has soared by over 1,257% from the lowest level in September, giving it a market cap of nearly $50 million.

Femasys (FEMY) shares fell 13% premarket on Wednesday after the biomedical company announced an offering to raise $3.9M.The company is selling 3,196,722 shares of common stock (or...Maxim Group analyst Jason McCarthy has maintained their bullish stance on FEMY stock, giving a Buy rating today.. Jason McCarthy’s Buy rating for Femasys (FEMY) is influenced by several factors ...Its stock ran from $0.33 to an intraday high of $4.75 a few days later, only to fall back to the $1 range. During that flurry of activity, the Company used its ATM to raise $11.3M.-- Thought leader from top-ranked academic gynecology program to lead clinical and medical affairs at Femasys --ATLANTA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible …Snap Inc. 12.52. +0.21. +1.71%. Get Sea Ltd (SE:NYSE) real-time stock quotes, news, price and financial information from CNBC.26 Sep 2023 ... Here I Show FEMY Stock (Femasys stock) FEMY STOCK PREDICTION FEMY STOCK analysis FEMY stock news today and also femy stock forecast ...It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...

Oct 2, 2023 · Recent News. The remarkable Femasys (NASDAQ: FEMY) stock price comeback continued on Monday as demand for the shares continued. The shares surged by more than 45% on Friday and gained by another 15% in the pre-market session. It has soared by over 1,257% from the lowest level in September, giving it a market cap of nearly $50 million.

10/03/23 8:49 AM. Post #257. – Femasys demonstrates compliance with harmonized regulatory requirements for Australia, Brazil, Japan, Canada and the USA –. – Femasys (FEMY) is committed to bringing innovative solutions to women around the world –.

Webull offers Femasys Inc stock information, including NASDAQ: FEMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FEMY stock news, and many more online research tools to help you make informed decisions.We would like to show you a description here but the site won’t allow us.Nov 28, 2023 · Its stock ran from $0.33 to an intraday high of $4.75 a few days later, only to fall back to the $1 range. During that flurry of activity, the Company used its ATM to raise $11.3M. Find the latest news headlines from Femasys Inc. Common Stock (FEMY) at Nasdaq.com. InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Shares of biomedical firm Femasys (NASDAQ:FEMY) more than doubled on Thursday.This followed an important intellectual property (IP ...RTTNews. Nov. 15, 2023, 08:41 AM. (RTTNews) - PharmaCyte Biotech, Inc. (PMCB) has made a $5 million investment in Femasys, Inc. (FEMY), a biomedical company. Femasys offers a broad portfolio of in ...According to the issued ratings of 3 analysts in the last year, the consensus rating for Femasys stock is Buy based on the current 3 buy ratings for FEMY. The average twelve-month price prediction for Femasys is $9.00 with a high price target of $10.00 and a low price target of $7.00. Learn more on FEMY's analyst rating history.Get the latest Femasys Inc. (FEMY) stock news and headlines to help you in your trading and investing decisions.Nov 14, 2023 · The average trading volume of FEMY on November 14, 2023 was 9.91M shares. FEMY) stock’s latest price update. Femasys Inc (NASDAQ: FEMY)’s stock price has decreased by -14.75 compared to its previous closing price of 1.22. However, the company has seen a -20.00% decrease in its stock price over the last five trading sessions.

Sep 25, 2023 · ATLANTA, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative diagnostic products, today announced it has received 510(k ... Femasys Inc. 0.9770. -0.0330. -3.27%. Recent events, particularly the reversal of the long-standing Roe v. Wade decision that guaranteed women’s right to have an abortion, have put women’s ...FEMY stock initially gained 150% before settling slightly lower. According to the USPTO website, should the government agency reasonably assess that an applicant is entitled to a patent under the ...PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (PharmaCyte or the Company) announces it has made a $5 million investment in Femasys, Inc. (Nasdaq:FEMY) (Femasys), a biomedical company focused on meeting... Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2023 and Provides Corporate Update Globe Newswire • …Instagram:https://instagram. costco instockt bill 3 month rateearnings calendar kiplingersmdd By Eddie Pan, InvestorPlace Financial News Writer Sep 29, 2023, 12:18 pm EST. The cost to borrow T2 Biosystems ( TTOO) tallies in at 37.62%, compared to 16.06% on Sept. 18. Meanwhile, 10% owner CR ...About FEMY. our experienced management team has over 200 years of collective industry experience with extensive focus in medical devices. the pioneering and collaborative efforts of the management team have created an organization that strives for integrity in all actions, innovation in development activities, excellence in operations, and the ... update on uaw strikeark forecast A high-level overview of Femasys Inc. (FEMY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. best va cash out refinance lenders Femasys Inc.is a biomedical company focused on transforming women's healthcare by developing novel solutions as well as providing significant clinical impact to address severely underserved areas. The company's lead product candidates offer FemBloc and FemaSeed. Femasys Inc. is based in ATLANTA. Stock split history for Femasys since 2021.Shares of FEMY are up on very heavy trading volume. According to data from Benzinga Pro, more than 66 million shares have already been traded on Friday, far exceeding the stock's 100-day average ...The public float for FEMY is 19.48M, and currently, short sellers hold a 2.20% ratio of that floaft. The average trading volume of FEMY on November 24, 2023 was 10.08M shares. FEMY’s Market Performance. FEMY’s stock has seen a -9.52% decrease for the week, with a -26.31% drop in the past month and a 141.36% gain in the past quarter.